Perrigo Seeks Tax Advantages with Elan Acquisition
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 8 (Table of Contents)
Published: 5 Aug-2013
DOI: 10.3833/pdr.v2013.i8.1969 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to reduce its tax bill, OTC drug maker Perrigo has agreed to acquire Ireland-based Elan for approximately US$8...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS